HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

OPC 20011

an oxaisocephem antibiotic; incorrect structure given in first source

Also Known As:

OPC-20011

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - OPC 20011: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Lactams: 2198
    - OPC 20011: 1

Related Diseases

1.	Respiratory Tract Infections (Respiratory Tract Infection) 11/01/1998 - "OPC-20011 produced a significant decrease of viable counts in lung tissue at a dose of 2.5 mg/kg of body weight, an efficacy similar to that of ampicillin at a dose of 10 to 20 mg/kg on an experimental murine model of respiratory tract infection caused by non-ampicillin-susceptible S. "
2.	Infections 11/01/1998 - "The in vivo activities of OPC-20011 were comparable to or greater than those of reference compounds in murine models of systemic infection caused by gram-positive and -negative pathogens. " 11/01/1998 - "OPC-20011 was up to 10 times as effective as vancomycin against MRSA infections in mice. "
3.	Body Weight (Weight, Body) 11/01/1998 - "OPC-20011 produced a significant decrease of viable counts in lung tissue at a dose of 2.5 mg/kg of body weight, an efficacy similar to that of ampicillin at a dose of 10 to 20 mg/kg on an experimental murine model of respiratory tract infection caused by non-ampicillin-susceptible S. "

Related Drugs and Biologics

1.	Vancomycin
2.	Ampicillin (Omnipen)